Zhang Y, Wang Y, Peng J, Zhao K, Li L, Zhang Y
Front Oncol. 2025; 15:1516867.
PMID: 39990687
PMC: 11842334.
DOI: 10.3389/fonc.2025.1516867.
Shekhawat J, Sharma J, Choudhury B, Chugh A, Purohit P, Sharma P
Mol Biol Rep. 2025; 52(1):152.
PMID: 39847241
DOI: 10.1007/s11033-025-10250-7.
Acharya S, Shai S, Choon Y, Gunardi I, Hartanto F, Kadir K
Biomedicines. 2024; 12(9).
PMID: 39335624
PMC: 11429394.
DOI: 10.3390/biomedicines12092111.
Moratin J, Horn D, Oehme M, Semmelmayer K, Flechtenmacher C, Ristow O
Clin Oral Investig. 2024; 28(6):327.
PMID: 38764079
PMC: 11102874.
DOI: 10.1007/s00784-024-05711-5.
Sharma S, Rai S, Misra D, Misra A, Sharma S, Sharma A
Contemp Clin Dent. 2024; 15(1):3-9.
PMID: 38707674
PMC: 11068250.
DOI: 10.4103/ccd.ccd_23_21.
Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.
Hirai R, Kinugasa H, Yamamoto S, Ako S, Tsutsumi K, Abe M
Br J Cancer. 2024; 130(10):1725-1731.
PMID: 38538728
PMC: 11091138.
DOI: 10.1038/s41416-024-02654-2.
Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma.
Sarubo M, Mouri Y, Moromizato A, Yamada A, Jin S, Shao W
Sci Rep. 2024; 14(1):6767.
PMID: 38514830
PMC: 10957997.
DOI: 10.1038/s41598-024-57478-0.
Gender Difference in DNA Damage Induced by the Environmental Carcinogen Dibenzo[]chrysene Individually and in Combination with Mouse Papillomavirus Infection in the Mouse Oral Cavity.
Chen K, Sun Y, Hu J, Balogh K, Gowda K, Aliaga C
ACS Omega. 2024; 9(7):8434-8438.
PMID: 38405470
PMC: 10882652.
DOI: 10.1021/acsomega.3c09611.
Dynamic Up-Regulation of PD-L1 in the Progression of Oral Squamous Cell Carcinoma.
Steen S, Semmelmayer K, Flechtenmacher C, Hoffmann J, Freier K, Horn D
Int J Mol Sci. 2023; 24(22).
PMID: 38003576
PMC: 10671831.
DOI: 10.3390/ijms242216386.
Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review.
Stoth M, Meyer T, Gehrke T, Hagen R, Scheich M, Hackenberg S
Oncol Lett. 2023; 26(5):489.
PMID: 37818135
PMC: 10561138.
DOI: 10.3892/ol.2023.14076.
A Prospective Observational Study on the Role of Immunohistochemical Expression of Orphanin in Laryngeal Squamous Cell Carcinoma Recurrence.
Sireci F, Lorusso F, Dispenza F, Immordino A, Gallina S, Salvago P
J Pers Med. 2023; 13(8).
PMID: 37623462
PMC: 10455511.
DOI: 10.3390/jpm13081211.
Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer.
Shao B, Ye Z, Sun B, Xiao Z
Biomolecules. 2023; 13(7).
PMID: 37509156
PMC: 10377423.
DOI: 10.3390/biom13071120.
Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal Tumors.
Colevas S, Merfeld E, Pflum Z, Gessert T, Wieland A, Glazer T
OTO Open. 2023; 7(1):e35.
PMID: 36998565
PMC: 10046711.
DOI: 10.1002/oto2.35.
The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy.
Setia Budi H, Younus L, Hadi Lafta M, Parveen S, Mohammad H, Al-Qaim Z
Front Oncol. 2023; 12:1067974.
PMID: 36793341
PMC: 9923359.
DOI: 10.3389/fonc.2022.1067974.
Cancer cell-derived novel periostin isoform promotes invasion in head and neck squamous cell carcinoma.
Wenhua S, Tsunematsu T, Umeda M, Tawara H, Fujiwara N, Mouri Y
Cancer Med. 2023; 12(7):8510-8525.
PMID: 36691359
PMC: 10134278.
DOI: 10.1002/cam4.5601.
Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer.
Sachdeva A, Dhawan D, Jain G, Yerer M, Collignon T, Tewari D
Cancers (Basel). 2023; 15(1).
PMID: 36612264
PMC: 9818473.
DOI: 10.3390/cancers15010268.
SHMT2 Induces Stemness and Progression of Head and Neck Cancer.
Jin Y, Jung S, Lim M, Oh C, Piao Y, Kim H
Int J Mol Sci. 2022; 23(17).
PMID: 36077112
PMC: 9456418.
DOI: 10.3390/ijms23179714.
Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
Farris J, Steber C, Black P, Chan M, Ververs J, Cramer C
Head Neck. 2022; 44(11):2571-2578.
PMID: 36047613
PMC: 9813854.
DOI: 10.1002/hed.27176.
High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma.
Callahan S, Kochat V, Liu Z, Raman A, Divenko M, Schulz J
Front Cell Dev Biol. 2022; 10:936168.
PMID: 35927986
PMC: 9343809.
DOI: 10.3389/fcell.2022.936168.
Proteases and HPV-Induced Carcinogenesis.
Vieira G, Somera Dos Santos F, Lepique A, da Fonseca C, Innocentini L, Braz-Silva P
Cancers (Basel). 2022; 14(13).
PMID: 35804810
PMC: 9264903.
DOI: 10.3390/cancers14133038.
